16 junio 2016

Lymphoma News Today .


Phase 2 Study of Plitidepsin, a Potential Treatment for Rare T-cell Lymphoma, Begins .

 
Daniela Semedo PhDBY DANIELA SEMEDO PHD

IN NEWS.
en